| Literature DB >> 28577038 |
Weiwei Shi1, Bryant V McIver1, Kanika Kalra1, Eric L Sarin1,2, Susan Schmarkey1, Michael Duggan1,3, Vinod H Thourani1, Robert A Guyton1, Muralidhar Padala4.
Abstract
Ischemic mitral regurgitation (IMR) is a frequent complication after a myocardial infarction (MI), which doubles mortality. Transcatheter mitral repairs are emerging as alternative treatment options to open heart surgery for IMR, but animal models to test them are lacking. We report a percutaneous swine model of IMR. Seventeen swine were randomized to (group 1, n = 12) MI causing IMR, and (group 2, n = 5) controls. In group 1, MI was induced via percutaneous ethanol injection into the obtuse marginal branches of the left circumflex artery, resulting in ST elevating myocardial infarction. Nine animals were survived to 8-10 weeks with weekly echocardiograms and three swine were survived to 16-20 weeks with MRI at termination. In group 1 animals, average IMR fraction at termination was 26.6 ± 2.3% in the echo group, and 24.51 ± 0.41% in the MRI group. None of the animals in group 2 had IMR. Left ventricular dysfunction and significant dilatation were evident in group 1 animals, compared to the controls. In conclusion, a reproducible model of IMR is reported for use in pre-clinical testing of new mitral technologies.Entities:
Keywords: Animal models; Annular dilatation; Annuloplasty; Cardiomyopathy; Functional mitral regurgitation; Heart failure; Mitral annulus; Mitral insufficiency; Transapical valve; Transcatheter mitral valve repair; Transcatheter mitral valve replacement; Valvular heart disease
Mesh:
Substances:
Year: 2017 PMID: 28577038 DOI: 10.1007/s12265-017-9751-3
Source DB: PubMed Journal: J Cardiovasc Transl Res ISSN: 1937-5387 Impact factor: 4.132